Losartan Potassium
Product Images NDC 67046-449

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 67046-449). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Losart100.449

Losartan Potassium 100 mg tablet label, indicating a bottle of 30 tablets. The label includes storage instructions, dosage notice to see the package insert, and identifies the product as film-coated tablets containing Losartan potassium USP 100 mg. The label is packaged by Contract Pharmacy Services-PA, Warrington, PA, with an NDC number 67046-449-30.*

FDA Label Image

Losart50.455

Losartan Potassium 50 mg tablet label from Contract Pharmacy Services-PA. The label indicates a quantity of 30 tablets, prescription use only. It includes storage instructions and states each film-coated tablet contains Losartan Potassium USP 50 mg. The label features barcodes, lot number H180645, and an expiration date of 06/27/19.*

FDA Label Image

Figure-1 (Losartan Fig1)

A line chart comparing the percentage of patients with primary endpoint events over a 66-month study period for Atenolol and Losartan Potassium. The chart shows adjusted risk reduction and includes a p-value indicating statistical significance.*

FDA Label Image

Figure-2 (Losartan Fig2)

A line graph comparing the percentage of patients with fatal or non-fatal stroke over study months for Losartan Potassium and Atenolol. The solid line represents Losartan Potassium, and the dotted line represents Atenolol, showing a lower risk increase with Losartan Potassium. The graph notes an adjusted risk reduction of 25% with Losartan Potassium, with a p-value of 0.001.*

FDA Label Image

Figure 3 (Losartan Fig3)

Figure depicting primary endpoint events within demographic subgroups comparing Losartan Potassium and Atenolol. The chart shows hazard ratios with 95% confidence intervals for primary composite events and stroke (fatal/non-fatal) across various categories such as age, gender, race, ISH status, diabetes, and history of cardiovascular disease.*

FDA Label Image

Figure-4 (Losartan Fig4)

A Kaplan-Meier curve graph comparing the percentage of patients with events over 48 months between Losartan Potassium and placebo groups. The solid line represents Losartan Potassium, and the dashed line represents placebo, showing risk reduction and statistical significance (p=0.022).*

FDA Label Image

Chemical Structure (Losartan Str)

Chemical structure diagram of losartan potassium, illustrating its chemical bonds and atomic composition, including the potassium ion (K+).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.